7-Deaza cyclic adenosine 5'-diphosphate ribose: First example of a Ca2+-mobilizing partial agonist related to cyclic adenosine 5'-diphosphate ribose

Citations of this article
Mendeley users who have this article in their library.


Background: Cyclic adenosine 5'-diphosphate ribose (cADPR), a naturally occurring metabolite of nicotinamide adenine dinucleotide (NAD+), mobilizes Ca2+ from non-mitochondrial stores in a variety of mammalian and invertebrate tissues. It has been shown that cADPR activates ryanodine-sensitive Ca2+-release channels, working independently of inositol 1,4,5-trisphosphate (IP3) to mobilize intracellular Ca2+ stores. In some systems, cADPR has been shown to be more potent than IP3. The chemo-enzymatic synthesis of structurally modified analogues of cADPR can provide pharmacological tools for probing this new Ca2+-signaling pathway. In this work, we describe the synthesis and evaluation of a structural mimic of cADPR with different Ca2+-releasing properties. Results: 7-Deaza cyclic adenosine 5'-diphosphate ribose (7-deaza cADPR), a novel cADPR analogue modified in the purine ring, was synthesized and its ability to release Ca2+ from non-mitochondrial pools in homogenates made from sea urchin eggs was investigated. 7-Deaza cADPR was more effective in releasing Ca2+ than cADPR, but it only released approximately 66% of the Ca2+ released by a maximal concentration of cADPR. It was also more resistant to hydrolysis than cADPR. If we administered increasing concentrations of 7-deaza cADPR at the same time as a maximal concentration of cADPR, the induction of Ca2+ release by cADPR was antagonized. Conclusions: 7-Deaza cADPR has a Ca2+-release profile consistent with that of a partial agonist, and it is the first reported example of such a compound to act at the cADPR receptor. The imidazole ring of cADPR is clearly important in stimulating the Ca2+-release machinery, and the present results demonstrate that structural modification of a site other than position 8 of the purine ring can affect the efficacy of Ca2+ release. 7-Deaza cADPR represents a significant step forwards in designing modulators of the cADPR signaling pathway.

Author supplied keywords




Bailey, V. C., Sethi, J. K., Fortt, S. M., Galione, A., & Potter, B. V. L. (1997). 7-Deaza cyclic adenosine 5’-diphosphate ribose: First example of a Ca2+-mobilizing partial agonist related to cyclic adenosine 5’-diphosphate ribose. Chemistry and Biology, 4(1), 51–61. https://doi.org/10.1016/S1074-5521(97)90236-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free